Market Tracker

06/24 5:16pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

0.4488
Delayed Data
As of Jun 24
 -0.0491 / -9.86%
Today’s Change
0.35
Today|||52-Week Range
5.04
-73.91%
Year-to-Date

Today’s Trading

Previous close0.50
Today’s open0.46
Day’s range0.45 - 0.47
Volume10,864,859
Average volume (3 months)2,543,795
Market cap$65.3M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-9.62%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.02+1.54%
DRNADicerna Pharmaceutic...-0.13-3.95%
CPRXCatalyst Pharmaceuti...-0.09-9.77%
NWBONorthwest Biotherape...-0.05-7.95%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts